ArticleInflammatory bowel diseases2023

Health-Related Quality of Life Outcomes With Tofacitinib Treatment in Patients With Ulcerative Colitis in the Open-Label Extension Study, OCTAVE Open.

Luc Biedermann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.